Balentine LLC Bio Techne Corp Transaction History
Balentine LLC
- $2.3 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding TECH
# of Institutions
619Shares Held
156MCall Options Held
161KPut Options Held
12.7K-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$926 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.7MShares$658 Million0.09% of portfolio
-
State Street Corp Boston, MA6.47MShares$400 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.76MShares$294 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.42B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...